Prognostic bioindicators in severe COVID-19 patients

L Bergantini, E Bargagli, M d'Alessandro, RM Refini… - Cytokine, 2021 - Elsevier
Background Severe acute respiratory syndrome caused by novel coronavirus 2 (SARS-CoV-
2) emerged in Wuhan (China) in December 2019. Here we evaluated a panel of biomarkers …

Prognostic bioindicators in severe COVID-19 patients

L Bergantini, E Bargagli, M D'Alessandro, RM Refini… - …, 2021 - usiena-air.unisi.it
Background: Severe acute respiratory syndrome caused by novel coronavirus 2 (SARS-CoV-
2) emerged in Wuhan (China) in December 2019. Here we evaluated a panel of biomarkers …

Prognostic bioindicators in severe COVID-19 patients

L Bergantini, E Bargagli, M d'Alessandro… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Severe acute respiratory syndrome caused by novel coronavirus 2 (SARS-CoV-
2) emerged in Wuhan (China) in December 2019. Here we evaluated a panel of biomarkers …

[HTML][HTML] Prognostic bioindicators in severe COVID-19 patients

L Bergantini, E Bargagli, M d'Alessandro, RM Refini… - Cytokine, 2021 - ncbi.nlm.nih.gov
Background Severe acute respiratory syndrome caused by novel coronavirus 2 (SARS-CoV-
2) emerged in Wuhan (China) in December 2019. Here we evaluated a panel of biomarkers …

Prognostic bioindicators in severe COVID-19 patients.

L Bergantini, E Bargagli, M d'Alessandro, RM Refini… - 2021 - cabidigitallibrary.org
Background: Severe acute respiratory syndrome caused by novel coronavirus 2 (SARS-CoV-
2) emerged in Wuhan (China) in December 2019. Here we evaluated a panel of biomarkers …

Prognostic bioindicators in severe COVID-19 patients.

L Bergantini, E Bargagli, M d'Alessandro, RM Refini… - Cytokine, 2021 - europepmc.org
Background Severe acute respiratory syndrome caused by novel coronavirus 2 (SARS-CoV-
2) emerged in Wuhan (China) in December 2019. Here we evaluated a panel of biomarkers …